Search Within

Joel Sheinfeld

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (15)
  3. Conference Paper (1)
Groups
  1. Biostatistics Service (34)
  2. Epidemiology and Biostatistics (34)
  3. Surgery (34)
  4. Urology (34)
  5. Department of Medicine (30)
  6. Genitourinary Oncology Service (30)

More Groups

People
  1. Darren Feldman (29)
  2. George Bosl (29)
  3. Robert Motzer (25)
  4. Sujata Patil (25)
  5. Dean Bajorin (23)
  6. Victor Reuter (15)

More People

Years
  1. 2024 (1)
  2. 2021 (3)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (3)
  6. 2017 (2)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Cancer (2)
  3. Urology (2)
  4. American Journal of Epidemiology (1)
  5. Annals of Thoracic Surgery (1)
  6. Biology of Blood and Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Elsevier Science, Inc. (3)
  3. Wiley Blackwell (3)
  4. Elsevier Inc. (2)
  5. Oxford University Press (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of a multimodal treatment paradigm to accelerate drug evaluations in early-stage metastatic prostate cancer
    Journal Article

    O'Shaughnessy, M. J.; McBride, S. M.; Vargas, H. A.; Touijer, K. A.; Morris, M. J.; Danila, D. C.; Laudone, V. P.; Bochner, B. H.; Sheinfeld, J.; Dayan, E. S.; more...
    Urology (2017)

    Fulltext@MSK | Save
  • Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors
    Journal Article

    Bagrodia, A.; Lee, B. H.; Lee, W.; Cha, E. K.; Sfakianos, J. P.; Iyer, G.; Pietzak, E. J.; Gao, S. P.; Zabor, E. C.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Actionable targets in patients with cisplatin-resistant advanced germ cell tumors
    Meeting Abstract

    Bagrodia, A.; Kaffenberger, S. D.; Lee, B.; Lee, W.; Cha, E. K.; Sfakianos, J.; Gao, S. P.; Zabor, E. C.; Ostrovnaya, I.; Eng, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide, and cisplatin efficacy for first-line treatment of patients with intermediate- or poor-risk germ cell tumors
    Journal Article

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Lim, K.; Patil, S.; Woo, K. M.; Carousso, M.; Hughes, A.; Sheinfeld, J.; Bains, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II trial of paclitaxel with ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin (TI-TIC) with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Journal Article

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • Association of genomic alterations with cisplatin resistance (cisR) in advanced germ cell tumors (aGCT)
    Meeting Abstract

    Feldman, D. R.; Bagrodia, A.; Lee, B.; Lee, W.; Al-Ahmadie, H.; Cha, E. K.; Sfakianos, J.; Iyer, G.; Zabor, E. C.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Acute changes in endothelial function with cisplatin among germ cell tumor (GCT) patients (Pts)
    Meeting Abstract

    Feldman, D. R.; Jacobsen, E. P.; Woo, K.; Steingart, R.; Fleisher, M.; Patil, S.; Carousso, M.; Laguerre, S.; Morales, T. D.; Sheinfeld, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I/II study of paclitaxel plus ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Meeting Abstract

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Long-term survival rates after chemotherapy (CTx) in patients (pts) with nonseminomatous (NS) germ cell tumors (GCT) with teratoma (T)
    Meeting Abstract

    Patil, S.; Feldman, D. R.; Bajorin, D. F.; Motzer, R. J.; Sheinfeld, J.; Tickoo, S.; Reuter, V. E.; Bosl, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save